FibroGen Inc (NASDAQ:FGEN) Q4 2022 Earnings Call dated Feb. 27, 2023. Corporate Participants: Michael Tung -- Vice President, Corporate Strategy and Investor Relations Enrique
Categories
Health Care
Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary
The global pharmaceutical market is expected to cross $1.5 trillion this year, which represents a 4-5% annual growth over the past five
Infographic: Ocean Biomedical Inc. (OCEA) quarter ended September 30, 2022
Ocean Biomedical, Inc. (NASDAQ: OCEA) was formed through the combination of Aesther Healthcare Acquisition Corp. with Ocean Biomedical. Here’s a look at the company’s
Infographic: Ocean Biomedical Inc. (OCEA) quarter ended June 30, 2022
Ocean Biomedical, Inc. (NASDAQ: OCEA) was formed through the combination of Aesther Healthcare Acquisition Corp. with Ocean Biomedical. Here are the company’s numbers for
Moderna Inc (MRNA) Q4 2022 Earnings Call Transcript
Moderna Inc (NASDAQ:MRNA) Q4 2022 Earnings Call dated Feb. 23, 2023. Corporate Participants: Lavina Talukdar -- Head of Investor Relations Stephane Bancel -- Chief Executive Officer
Moderna (MRNA) Earnings: 4Q22 Key Numbers
Moderna Inc. (NASDAQ: MRNA) reported total revenue of $5.1 billion for the fourth quarter of 2022, down 29% year-over-year due to a
Medtronic PLC (MDT) Q3 2023 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q3 2023 earnings call dated Feb. 21, 2023 Corporate Participants: Ryan Weispfenning -- Vice President and Head of Investor Relations
Key highlights from Medtronic’s (MDT) Q3 2023 earnings results
Medtronic plc (NYSE: MDT) reported third quarter 2023 earnings results today. Revenue of $7.7 billion was flat as reported and up 4.1% organically compared
Ironwood Pharmaceuticals Inc (IRWD) Q4 2022 Earnings Call Transcript
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Q4 2022 earnings call dated Feb. 16, 2023 Corporate Participants: Matt Roache -- Director of Investor Relations Thomas McCourt -- Chief
Sage Therapeutics Inc (SAGE) Q4 2022 Earnings Call Transcript
Sage Therapeutics Inc (NASDAQ: SAGE) Q4 2022 earnings call dated Feb. 16, 2023 Corporate Participants: Helen Rubinstein -- Director of Investor Relations Barry Greene -- Chief
10X Genomics Inc (TXG) Q4 2022 Earnings Call Transcript
10X Genomics Inc (NASDAQ: TXG) Q4 2022 earnings call dated Feb. 15, 2023 Corporate Participants: Cassie Corneau -- Manager, Investor Relations and Strategic Finance
Biogen, Inc. (BIIB) Q4 2022 Earnings Call Transcript
Biogen, Inc. (NASDAQ: BIIB) Q4 2022 earnings call dated Feb. 15, 2023 Corporate Participants: Michael Hencke -- Head of Investor Relations Christopher A. Viehbacher -- President
Key highlights from Biogen’s (BIIB) Q4 2022 earnings results
Biogen Inc. (NASDAQ: BIIB) reported fourth quarter 2022 earnings results today. Total revenue fell 7% year-over-year to $2.54 billion. Net income attributable
Zoetis Inc (ZTS) Q4 2022 Earnings Call Transcript
Zoetis Inc (NYSE: ZTS) Q4 2022 earnings call dated Feb. 14, 2023 Corporate Participants: Steve Frank -- Vice President, Investor Relations Kristin Peck -- Chief Executive
AbbVie sees near-term slowdown; looks prepared to tackle patent expiration
AbbVie, Inc. (NYSE: ABBV) has delivered yet another quarter of strong top-line and earnings performance but issued cautious guidance for fiscal 2023
Ventas Inc (VTR) Q4 2022 Earnings Call Transcript
Ventas Inc (NYSE: VTR) Q4 2022 earnings call dated Feb. 10, 2023 Corporate Participants: BJ Grant -- Senior Vice President-Investor Relations Debra A. Cafaro -- Chairman and
IQVIA Holdings Inc (IQV) Q4 2022 Earnings Call Transcript
IQVIA Holdings Inc (NYSE: IQV) Q4 2022 earnings call dated Feb. 10, 2023 Corporate Participants: Nick Childs -- Senior Vice President - Investor Relations and
Vertex Pharmaceuticals (VRTX) Earnings: 4Q22 Key Numbers
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported total revenues of $2.3 billion for the fourth quarter of 2022. This compares to $2 billion in
Veru Inc (VERU) Q1 2023 Earnings Call Transcript
Veru Inc (NASDAQ: VERU) Q1 2023 earnings call dated Feb. 09, 2023 Corporate Participants: Sam Fisch -- Executive Director, Investor Relations, and Corporate Communications Mitchell
AstraZeneca PLC (AZN) Q4 2022 Earnings Call Transcript
AstraZeneca PLC (NYSE: AZN) Q4 2022 earnings call dated Feb. 09, 2023 Corporate Participants: Andy Barnett -- Vice President Global Head of Investor Relations Pascal
Canopy Growth Corporation (WEED) Q3 2023 Earnings Call Transcript
Canopy Growth Corporation (TSE: WEED) Q3 2023 earnings call dated Feb. 09, 2023 Corporate Participants: Tyler Burns -- Director, Investor Relations David Klein -- Chief Executive